Page last updated: 2024-09-05

sb 203580 and 15-hydroxy-5,8,11,13-eicosatetraenoic acid

sb 203580 has been researched along with 15-hydroxy-5,8,11,13-eicosatetraenoic acid in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(15-hydroxy-5,8,11,13-eicosatetraenoic acid)
Trials
(15-hydroxy-5,8,11,13-eicosatetraenoic acid)
Recent Studies (post-2010) (15-hydroxy-5,8,11,13-eicosatetraenoic acid)
3,48941,13774213110

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giribaldi, G; Khadjavi, A; Prato, M; Valente, E1

Other Studies

1 other study(ies) available for sb 203580 and 15-hydroxy-5,8,11,13-eicosatetraenoic acid

ArticleYear
Involvement of p38 MAPK in haemozoin-dependent MMP-9 enhancement in human monocytes.
    Cell biochemistry and function, 2014, Volume: 32, Issue:1

    Topics: Cell Adhesion; Female; Hemeproteins; Humans; Hydroxyeicosatetraenoic Acids; Imidazoles; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Male; Matrix Metalloproteinase 9; Monocytes; p38 Mitogen-Activated Protein Kinases; Phagocytosis; Phosphorylation; Pigments, Biological; Plasmodium falciparum; Protein Serine-Threonine Kinases; Pyridines

2014